aspartic acid has been researched along with oxotremorine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Aas, P | 1 |
| Costi, A; Marchi, M; Raiteri, M; Volpe, G | 1 |
| Expósito, I; Mora, F; Sanz, B | 1 |
| Lee, YJ; Tsai, LH; Wu, J | 1 |
| Jaen, JC; Mirzadegan, T; Moreland, D; Schwarz, RD; Spencer, CJ; Tecle, H; Thomas, AJ | 1 |
| Fisher, SK; Gurda, GT; Heacock, AM; Kerley, D; VanTroostenberghe, AT | 1 |
7 other study(ies) available for aspartic acid and oxotremorine
| Article | Year |
|---|---|
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Prejunctional control of cholinergic nerves in airway smooth muscle exerted by muscarinic, purinergic and glutamergic receptors.
Topics: Acetylcholine; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Aspartic Acid; Bronchi; Diamines; Gallamine Triethiodide; Glutamates; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Oxotremorine; Parasympatholytics; Rats; Rats, Inbred Strains; Receptors, Glutamate; Receptors, Muscarinic; Receptors, Neurotransmitter; Receptors, Purinergic; Trachea | 1990 |
Endogenous aspartate release in the rat hippocampus is inhibited by M2 'cardiac' muscarinic receptors.
Topics: Acetylcholine; Animals; Aspartic Acid; Calcium; Carbachol; Chromatography, High Pressure Liquid; Heart; Hippocampus; In Vitro Techniques; Male; Myocardium; Neuromuscular Depolarizing Agents; Oxotremorine; Pirenzepine; Potassium; Rats; Rats, Inbred Strains; Receptors, Muscarinic; Synaptosomes | 1990 |
M1 muscarinic receptor stimulation decreases aspartate release in the rat neostriatum.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Animals; Arecoline; Aspartic Acid; Chemotherapy, Cancer, Regional Perfusion; Extracellular Space; Glutamic Acid; Injections, Intraperitoneal; Male; Neostriatum; Oxotremorine; Rats; Rats, Wistar; Receptor, Muscarinic M1; Receptors, Muscarinic | 1997 |
Effect of excitatory amino acid neurotransmitters on acid secretion in the rat stomach.
Topics: 1-Methyl-3-isobutylxanthine; 2-Amino-5-phosphonovalerate; Animals; Aspartate Aminotransferases; Aspartic Acid; Cyclic AMP; Cyclic GMP; Excitatory Amino Acid Antagonists; Gastric Acid; Gastric Mucosa; Histamine; Histamine Release; Immunohistochemistry; In Vitro Techniques; Male; Muscarinic Agonists; Neurons; Oxotremorine; Pentagastrin; Piperazines; Rats; Rats, Sprague-Dawley; Stomach | 1999 |
Mutations of aspartate 103 in the Hm2 receptor and alterations in receptor binding properties of muscarinic agonists.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Alanine; Amino Acid Substitution; Animals; Arecoline; Asparagine; Aspartic Acid; Carbachol; COS Cells; Muscarinic Agonists; Mutagenesis, Site-Directed; Oxotremorine; Pilocarpine; Receptor, Muscarinic M2; Receptors, Muscarinic; Transfection | 1995 |
Potentiation of the osmosensitive release of taurine and D-aspartate from SH-SY5Y neuroblastoma cells after activation of M3 muscarinic cholinergic receptors.
Topics: Aspartic Acid; Cell Line, Tumor; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Ion Channels; Muscarinic Agonists; Muscarinic Antagonists; Neuroblastoma; Oxotremorine; Phosphatidylinositols; Protein-Tyrosine Kinases; Receptor, Muscarinic M3; Taurine; Water-Electrolyte Balance | 2004 |